Patton Curtis L. received 75,000 Tevogen Inc. shares in an award dated September 11, 2026, bringing his resulting holding to 139,192 shares. The transaction represented about 53.9% of that holding, giving investors a specific measure of the director’s post-award ownership and the size of the reported insider transaction.
Key Highlights
- The transaction was recorded on September 11, 2026.
- SEC transaction code A classifies the entry as an award or grant.
- Patton Curtis L.’s post-transaction holding was 139,192 shares.
Patton Curtis L. received 75,000 Tevogen Inc. (NASDAQ: TVGN) shares through an award dated September 11, 2026.
Award Date and Transaction Classification
The post-transaction holding was 139,192 Tevogen Inc. shares. Patton Curtis L. is identified as a director of Tevogen Inc. The filing identifies the transaction with SEC code A. The recorded ownership figure reflects the director’s position after the transaction. The 75,000 shares represented about 53.9% of Patton Curtis L.’s resulting holding.
FAQs
Q: How many Tevogen shares did Patton Curtis L. receive?
A: Patton Curtis L. received 75,000 Tevogen Inc. shares in the award. The transaction was dated September 11, 2026, and the filing identifies it with SEC transaction code A.
Q: What was Patton Curtis L.’s Tevogen share holding after the transaction?
A: His reported post-transaction holding was 139,192 Tevogen Inc. shares. Patton Curtis L. is identified as a director of Tevogen Inc.
Q: What does transaction code A mean for the Tevogen insider transaction?
A: Code A identifies an award or grant in the transaction classification. The entry concerns shares awarded to Patton Curtis L. rather than an open-market purchase or sale.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.